OMBLASTYS (omburtamab) Logo (EUIPO, 04/07/2020)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OMBLASTYS (omburtamab) was filed as Figurative mark on 04/07/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/24/2020.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Punctuation marks, brackets, quotation marks #Check sign #Lines or bands forming an angle #Letters containing written or typographical matter
| Trademark form | Figurative mark |
| File reference | 018222041 |
| Application date | April 7, 2020 |
| Publication date | April 16, 2020 |
| Entry date | July 24, 2020 |
| Expiration date | April 7, 2030 |
Trademark owner
230 Park Avenue, Suite 3350
NY 10169 New York
US
NY 10169 New York
US
Trademark representatives
Sommervej 31F, 3. tv
8210 Aarhus V
DK
goods and services
5
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
42
Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; Industrial analysis and research services in the field of chemistry
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 18, 2022 | Change Representative, Published | ||
| September 17, 2021 | Change Representative, Published |
ID: 11018222041